DCN and prostate carcinoma: Therefore, Xu et al. constructed a recombinant oncolytic adenovirus Ad-dcn carrying the human decorin gene, which could significantly reduce the expression of β-catenin, VEGFA and result in the inhibition of prostate cancer bone metastases [223].